Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer.

Xue, Yonggan; Ning, Bobin; Liu, Hongyi; Jia, Baoqing

Xue, Yonggan; Ning, Bobin; Liu, Hongyi; Jia, Baoqing.

Affiliation

Xue Y; Department of General Surgery, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China.
Ning B; Department of General Surgery, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China.
Liu H; Department of General Surgery, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China.
Jia B; Department of General Surgery, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People's Republic of China. baoqingjia@126.com.

BMC Gastroenterol ; 22(1): 127, 2022 Mar 17.

Article de En | MEDLINE | ID: mdl-35300596

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du côlon / Résistance aux médicaments antinéoplasiques / ARN long non codant / Immunité Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: BMC Gastroenterol Sujet du journal: GASTROENTEROLOGIA Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google